Neurotrope, Inc.
CIK 0001513856
Revenue (TTM)
—
Q3 Nov 2020
Net Income (TTM)
−$13.56M
−37.3% YoY
Q3 Nov 2020
EPS Diluted (TTM)
—
Q3 Nov 2020
Gross Margin
—
Q3 Nov 2020
Operating Margin
—
Q3 Nov 2020
Net Margin
—
Q3 Nov 2020
Free Cash Flow (TTM)
−$11.37M
Q3 Nov 2020
Cash
$27M
Q3 Nov 2020
Total Debt
—
Q3 Nov 2020
Shares Outstanding
23.79M sh
Q3 Nov 2020
Revenue & Net Income
Cash Flow
Revenue Growth (YoY)
No data available for this metric.